iBio, Inc.: cash_and_equivalents
| Value | {"amount": 56395000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2026-06-30) |
| Status | current |
| Entity | iBio, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-30T09:20:22.876619+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/350607a8-0327-42a1-a15f-9b13c06d19a1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001420720-26-000020Retrieved: 2026-08-30T09:20:22.876619+02:00
Raw response sha256:
a62a7c6a9bfea0d721a73ac9439b8a07…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001420720/cash-and-equivalents/2026-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/350607a8-0327-42a1-a15f-9b13c06d19a1
History
- no predecessors — first report